iosulamide
RN given refers to parent cpd; see also iosulamide meglumine
Also Known As:
iosulamide disodium salt
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
| 1. | Neoplasms (Cancer)
01/01/1982
- " Failure of iosulamide to enhance hepatic tumors in rats." 01/01/1982
- " This, together with the modest iodine concentrations found in the liver, suggests that iosulamide is of little use in computed tomography for the differential enhancement of liver and hepatic tumors." 01/01/1982
- " Since the distribution volume of cholangiographic contrast agents includes both vascular and interstitial space, the relatively high and prolonged iosulamide accumulation in tumors can be explained by a relatively large interstitial compartment, which is apparently characteristic of neoplastic lesions. " 01/01/1982
- " After intravenous injection of iosulamide in dosages of 140 and 280 mg iodine per kg, iodine concentrations were determined in blood, liver and tumors at 1, 5, 10, and 30 minutes, using x-ray energy spectrometry. " 01/01/1982
- " Iosulamide, an experimental cholangiographic agent recently being evaluated for hepatic contrast enhancement in computed tomography, has been investigated in the rat for the differential enhancement between the liver and three histologically different experimental tumors (a well differentiated mammary adenocarcinoma, a poorly differentiated colon carcinoma, and a hepatoma). "
|
| 2. | Hepatocellular Carcinoma (Hepatoma)
|
| 3. | Carcinoma (Carcinomatosis)
|
| 4. | Adenocarcinoma
|
|
Related Drugs and Biologics
Related Therapies and Procedures